A Phase 3 Molluscum Contagiosum Efficacy and Safety Study
Public ClinicalTrials.gov record NCT04535531. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study Comparing the Efficacy and Safety of SB206 and Vehicle Gel Once Daily in the Treatment of Molluscum Contagiosum
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a phase 3 multi-center, randomized, double-blind, vehicle-controlled, parallel group study to be conducted in up to approximately 850 subjects 6 months of age and older with molluscum contagiosum (MC). Subjects or their caregivers will apply SB206 10.3% or Vehicle Gel once daily for a minimum of 4 weeks and up to 12 weeks to all lesions identified at Baseline and new treatable lesions that arise during the course of the study.
Study identification
- NCT ID
- NCT04535531
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 891 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 6 Months and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 1, 2020 (Actual)
- Primary completion
- Apr 28, 2021 (Actual)
- Completion
- Jul 28, 2021 (Actual)
- Last update posted
- Jan 26, 2023
2020 – 2021
United States locations
- U.S. sites
- 55
- U.S. states
- 27
- U.S. cities
- 54
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site #312 | Glendale | Arizona | 85308 | — |
| Site #101 | Hot Springs | Arkansas | 71913 | — |
| Site #272 | Rogers | Arkansas | 72758 | — |
| Site #336 | Fountain Valley | California | 92708 | — |
| Site #329 | Fremont | California | 94538 | — |
| Site# 348 | Fresno | California | 93711 | — |
| Site #161 | San Diego | California | 92103 | — |
| Site #327 | Thousand Oaks | California | 91320 | — |
| Site #325 | Greenwood Village | Colorado | 80111 | — |
| Site #335 | Apopka | Florida | 32703 | — |
| Site #342 | Boca Raton | Florida | 33428 | — |
| Site #333 | Fort Lauderdale | Florida | 33316 | — |
| Site #334 | Homestead | Florida | 33030 | — |
| Site #278 | Miami | Florida | 33165 | — |
| Site #314 | Miami Lakes | Florida | 33014 | — |
| Site #341 | Orlando | Florida | 32829 | — |
| Site #227 | Sanford | Florida | 32771 | — |
| Site #305 | Tampa | Florida | 33163 | — |
| Site #116 | Newnan | Georgia | 30263 | — |
| Site #340 | Chicago | Illinois | 60611 | — |
| Site #253 | Rolling Meadows | Illinois | 60008 | — |
| Site #288 | Evansville | Indiana | 47715 | — |
| Site #310 | Plainfield | Indiana | 46168 | — |
| Site #328 | Bowling Green | Kentucky | 42101 | — |
| Site #347 | Lexington | Kentucky | 40517 | — |
| Site # 117 | Louisville | Kentucky | 40241 | — |
| Site #294 | Owensboro | Kentucky | 42301 | — |
| Site #321 | Baton Rouge | Louisiana | 70809 | — |
| Site# 349 | Covington | Louisiana | 70433 | — |
| Site #332 | New Orleans | Louisiana | 70119 | — |
| Site #297 | New Orleans | Louisiana | 70124 | — |
| Site #330 | Rockville | Maryland | 20854 | — |
| Site #346 | Brighton | Massachusetts | 02135 | — |
| Site #274 | Clarkston | Michigan | 48346 | — |
| Site #121 | New Brighton | Minnesota | 55112 | — |
| Site #338 | Omaha | Nebraska | 68114 | — |
| Site #201 | Berlin | New Jersey | 08009 | — |
| Site #331 | Verona | New Jersey | 07044 | — |
| Site #279 | Greensboro | North Carolina | 27408 | — |
| Site #250 | Portland | Oregon | 97210 | — |
| Site #265 | Sugarloaf | Pennsylvania | 18249 | — |
| Site #311 | Warwick | Rhode Island | 02866 | — |
| Site #295 | Fountain Inn | South Carolina | 29644 | — |
| Site #255 | Summerville | South Carolina | 29486 | — |
| Site #291 | Kingsport | Tennessee | 37660 | — |
| Site #326 | Knoxville | Tennessee | 37909 | — |
| Site #316 | Murfreesboro | Tennessee | 37130 | — |
| Site #337 | Houston | Texas | 77087 | — |
| Site #299 | Longview | Texas | 75605 | — |
| Site #224 | San Antonio | Texas | 78218 | — |
| Site #281 | Layton | Utah | 84041 | — |
| Site #345 | West Jordan | Utah | 84088 | — |
| Site #267 | Richmond | Virginia | 23294 | — |
| Site #339 | Spokane | Washington | 99202 | — |
| Site #343 | Morgantown | West Virginia | 26505 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04535531, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 26, 2023 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04535531 live on ClinicalTrials.gov.